Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Open-label, Single Arm Trial of BI 695502 in Patients With Previously Untreated Metastatic Colorectal Cancer

ClinicalTrials.gov ID: NCT02776683

Public ClinicalTrials.gov record NCT02776683. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 22, 2026, 4:04 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Single Arm, Open-label, Multicenter, Multinational, Safety and Efficacy Phase IIIb Trial of BI 695502 Plus mFOLFOX6 in Patients With Previously Untreated Metastatic Colorectal Cancer

Study identification

NCT ID
NCT02776683
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Boehringer Ingelheim
Industry
Enrollment
123 participants

Conditions and interventions

Interventions

  • BI 695502 Drug
  • Avastin Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 7, 2016
Primary completion
Oct 2, 2018
Completion
Oct 2, 2018
Last update posted
Nov 20, 2019

2016 – 2018

United States locations

U.S. sites
25
U.S. states
10
U.S. cities
22
Facility City State ZIP Site status
Mayo Clinic-Arizona Phoenix Arizona 85054
Pacific Cancer Medical Center, Inc. Anaheim California 92801
The Oncology Institute of Hope and Innovation Anaheim California 92801
Rocky Mountain Cancer Centers Denver Colorado 80218
Ashland Bellefonte Cancer Center Ashland Kentucky 41101
University of Michigan Health System Ann Arbor Michigan 48109
Washington University School of Medicine St Louis Missouri 63110
Aultman Hospital Canton Ohio 44710
Oncology Hematology Care Cincinnati Ohio 45242
Northwest Cancer Specialists PC Portland Oregon 97225
Willamette Valley Cancer Institute and Research Center Springfield Oregon 97477
Texas Oncology, P.A. Abilene Texas 79606
Texas Oncology, PA, Amarillo Texas 79106
Texas Oncology, P.A. Austin Texas 78705
Texas Oncology, P.A. Flower Mound Texas 75028
Texas Oncology, P.A. Garland Texas 75042-5788
Oncology Consultants, P.A. Houston Texas 77030
Texas Oncology, P.A. McAllen Texas 78503-1298
Texas Oncology, PA Mesquite Texas 75150
Texas Oncology-San Antonio Northeast San Antonio Texas 78217
Texas Oncology San Antonio Medical Center San Antonio Texas 78229
Tyler Hematology-Oncology, PA Tyler Texas 75701
Texas Oncology, P.A. Tyler Texas 75702
Texas Oncology, P.A., Deke Slayton Cancer Center Webster Texas 77598
Virginia Cancer Institute Richmond Virginia 23226

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 21 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02776683, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 20, 2019 · Synced Jul 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02776683 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →